Ten-year incidence of diabetic retinopathy and macular edema. Risk factors in a sample of people with type 1 diabetes

Diabetes Research and Clinical Practice

Volumn 94, Issue 1, 2011, Pages 126-132

  Romero Aroca, Pedro ^a   Baget Bernaldiz, Marc ^a   Fernandez Ballart, Juan ^b,c   Plana Gil, Nuria ^b   Soler Lluis, Nuria ^a   Mendez Marin, Isabel ^a   Bautista Perez, Angel ^a  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^b UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^c Instituto de Salud Carlos III   (Spain)

Author keywords

ApoB Apo A1 ratio; Apolipoproteins; Diabetic macular edema; Diabetic retinopathy; Diabetic retinopathy incidence; TC HDL C ratio

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN A1; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RETINA MACULA EDEMA; RISK FACTOR; SPAIN; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FEMALE; HUMANS; MACULAR EDEMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 80054878039     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.07.004     Document Type: Article

References (27)

1. King H., Aubert R.E., Herman W.H. burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care Glob 1998, 21:1414-1431.
2. The expert committee on the diagnosis and classification of diabetes mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2000, 23:S4-S19.
3. Klein R., Lee K.E., Gangnon R.E., Klein B.E. The 25-year incidence of visual impairment in type 1 diabetes mellitus the Wisconsin epidemiologic study of diabetic retinopathy. Ophthalmology 2010, 117:63-70.
4. Klein R., Knudtson M.D., Lee K.E., Gangnon R., Klein B.E. The Wisconsin epidemiologic study of diabetic retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology 2008, 115:1859-1868.
5. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS Report no 12. Ophthalmology 1991, 98:823-833. Early Treatment Diabetic retinopathy Study research Group.
6. Klein B.E., Klein R., Moss S.E. Is serum cholesterol associated with progression of diabetic retinopathy or macular edema in persons with younger onset diabetes of long duration?. Am J Ophthalmol 1999, 128:652-654.
7. Early photocoagulation for diabetic macular retinopathy. ETDRS report number 9. Ophthalmology 1991, 98:766-785. Early Treatment Diabetic Retinopathy Study Research Group.
8. The sixth report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med 1997, 157:2413-2442.
9. American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, International Diabetes Federation Consensus statement on the worldwide standardisation of the HbA1c measurement. Diabetologia 2007, 50:2042-2043.
10. A desktop guide to type I (insulin-dependent) diabetes mellitus. 1998-1999. Guidelines for Diabetes care. Diabetic Med 1999, 16:253-266. European Diabetes Policy Group.
11. Genest J., Frohlich J., Fodor G., McPherson R. Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: 2003 update. CMAJ 2003, 169:921-924. the Working Group on Hypercholesterolemia and Other Dyslipidemias.
12. Holme I., Aastveit A.H., Junger I., Walldius G. Relationships between lipoprotein components and risk of myocardial infarction: age gender and short versus longer follow-up periods in the apolipoprotein mortality risk study (AMORIS). J Intern Med 2008, 264:30-38.
13. Klein R., Klein B.E., Moss S.E., Cruickshanks K.J. The Wisconsin epidemiologic study of diabetic retinopathy. XIV. Ten year incidence and progression of diabetic retinopathy. Arch Ophthalmol 1994, 112:1217-1228.
14. White N.H., Sun W., Cleary P.A., Tamborlane W.V., Danis R.P., Hainsworth D.P., et al. Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents. Diabetes 2010, 59:1244-1253.
15. Chew E.Y., Klein M.L., Ferris F.L., Remaley N.A., Murphy R.P., Chantry K., et al. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy early treatment diabetic retinopathy study (ETDRS) report 22. Arch Ophthalmol 1996, 114:1079-1084.
16. Klein B.E., Moss S.E., Klein R., Surawicz T.S. The Wisconsin epidemiologic study of diabetic retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate. Ophthalmology 1991, 98:1261-1265.
17. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the diabetes control and complications trial cohort. Diabetes Care 1999, 22:99-111. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.
18. Wong T.Y., Klein R., Islam F.M., Cotch M.F., Folsom A.R., Klein B.E., et al. Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol 2006, 141:446-455.
19. Keech A.C., Mitchell P., Summanen P.A., O'Day J., Davis T.M., Moffitt M.S., et al. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet 2007, 17:1687-1697.
20. Mohan R., Mohan V., Susheela L., Ramachandran A., Viswanathan M. Increased LDL cholesterol in non-insulin-dependent diabetics with maculopathy. Acta Diabetol Lat 1984, 21:85-89.
21. Romero-Aroca P., Sagarra-Alamo R., Baget-bernaldiz M., Fernandez-ballart J., Mendez-marin I. Prevalence and relationship between diabetic retinopathy and nephropathy, and its risk factors in the North-East of Spain, a population-based study. Ophthalmic Epidemiol 2010, 17:251-265.
22. Lyons T.J., Jenkins A.J., Zheng D., Lackland D.T., McGee D., Garvey W.T., et al. Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. Invest Ophthalmol Vis Sci 2004, 45:910-918.
23. Gardner C.D., Fortmann S.P., Krauss R.M. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 1996, 276:875-881.
24. Sasongko M.B., Wong T.Y., Nguyen T.T., Kawasaki R., Jenkins A., Shaw J., et al. Serum apolipoprotein AI and B are stronger biomarkers of diabetic retinopathy than traditional lipids. Diabetes Care 2011, 34:474-479.
25. Simo R., Higuera M., Garci{dotless}a-Rami{dotless}rez M., Canals F., Garci{dotless}a-Arumi{dotless} J., Hernandez C. Elevation of apolipoprotein A-I and apolipoprotein H Levels in the vitreous fluid and overexpression in the retina of diabetic patients. Arch Ophthalmol 2008, 126:1076-1081.
26. Simo R., Villarroel M., Corraliza L., Hernández C., Garcia-Ramirez M. The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier-implications for the pathogenesis of diabetic retinopathy. J Biomed Biotechnol 2010, 190724. Epub 2010 Feb 17.
27. Joussen A.M., Murata T., Tsujikawa A., Kirchhof B., Bursell S.E., Adamis A.P. Leukocyte mediated endothelial cell injury and death in the diabetic retina. Am J Pathol 2001, 158:147-152.